Latest Breaking News On - திவ்யா பிரேம்குமார் - Page 1 : comparemela.com
Chinese EV Stocks: Why LI, XPEV, NIO Stocks Are Revving Up Today
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Chinese EV Stocks: Why LI, XPEV, NIO Stocks Are Revving Up Today
investorplace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorplace.com Daily Mail and Mail on Sunday newspapers.
Sundial Growers (NASDAQ:
SNDL) is a testament to the strength of retail investors in the stock market today, who have largely bid up SNDL stock as a speculative cannabis play.
That bull thesis gained some credibility today with the company’s announcement of a $22 million deal with
Indiva Limited, a Canadian cannabis producer specializing in edibles. Indiva, which trades on the
Approximately half of the deal will be realized via a private placement of NDVA stock, while another $11 million will come via non-revolving loan facility. The deal is set to close on Feb. 23, 2021 pending the necessary approvals.
While SNDL has been a big beneficiary of retail investor interest in recent weeks, many market observers have felt there was little to support the price action, or to suggest that the company is well-positioned to capitalize on that price action.
ETSY Stock: One Big Reason Why Etsy Shares Are on the Move Today Could an Elon Musk tweet be moving the craft-maker marketplace? Jan 26, 2021, 9:16 am EDT January 26, 2021
Etsy (NASDAQ:
ETSY) stock surged more than 8% in pre-market trading. But what is this pre-Valentine’s Day love all about?
Source: Shutterstock
Tesla (NASDAQ:
TSLA) founder’s Twitter feed, he bought a Marvin the Martian item for his dog. “I kinda love Etsy,” he tweeted. And now, the shares are among the top trending tickers ahead of Tuesday’s market open.
Lest you think the market has gone too far, don’t forget that an earlier tweet from the EV maker though misread led to a three-figure surge in biotech